Scientific work

Uzm. Dr. Erkut Demirciler

18 publications. The source of the information is stated next to each publication.

Back to profile

  1. Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16868-5 Open-access full textSource: OpenAlex

  2. Comparison of Baseline Systemic Inflammatory Indicators in Preoperative Treatment of Gastric Carcinoma

    Preprints.org, 2026

    DOI 10.20944/preprints202607.0514.v1 Open-access full textSource: OpenAlex

  3. Baseline Inflammatory and Nutritional Indices Show Limited Discrimination for Major Pathological Response and Survival After Neoadjuvant Chemotherapy for Gastric Cancer: A Retrospective Comparison of Eleven Indices

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15176893 PMID 42739899 Open-access full textSource: OpenAlex

  4. Opposing Natural Killer and Macrophage Associations Are Masked Within a CD16/IL-15/IL-15RA Composite Score in Metastatic Urothelial Carcinoma

    International Journal of Molecular Sciences, 2026

    DOI 10.3390/ijms27208943 PMID 42941720 Open-access full textSource: ORCID

  5. Clinicopathological features and survival of early-onset colon cancer: a SEER-based analysis of 156,031 curative-intent surgical patients

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1969236 Open-access full textSource: ORCID

  6. Neoadjuvant TCHP for Stage II-III HER2-positive Breast Cancer: A Real-world Cohort

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-3-1 Open-access full textSource: ORCID

  7. Integrative in silico transcriptomic and pharmacogenomic analysis of CD276 as a candidate prognostic biomarker and therapeutic target in bladder cancer

    Discover oncology, 2026

    DOI 10.1007/s12672-026-05310-8 PMID 42185660 Open-access full textSource: ORCID

  8. Prognostic stratification in gastric cancer with peritoneal metastasis: tumor biology and diagnostic modality as a surrogate for disease burden

    BMC cancer, 2026

    DOI 10.1186/s12885-026-15684-1 PMID 41634619 Open-access full textSource: ORCID

  9. Ovarian Cancer

    IntechOpen eBooks, 2026

    DOI 10.5772/intechopen.1016353 Open-access full textSource: OpenAlex

  10. Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study

    Medicina, 2025

    DOI 10.3390/medicina61050776 PMID 40428735 Open-access full textSource: OpenAlex

  11. Early Changes in Volumetric Body Composition Parameters Predict Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy

    Journal of clinical medicine, 2025

    DOI 10.3390/jcm14093140 PMID 40364170 1 citation (Europe PMC) Open-access full textSource: ORCID

  12. Prognostic Value of B7-H3 and a Novel Scoring System in Localized Renal Cell Carcinoma

    Medicina (Kaunas, Lithuania), 2025

    DOI 10.3390/medicina61050867 PMID 40428825 1 citation (Europe PMC) Open-access full textSource: ORCID

  13. Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study

    Cancers, 2024

    DOI 10.3390/cancers17010046 PMID 39796675 9 citations (Europe PMC) Open-access full textSource: ORCID

  14. Survival outcomes according to the tumor location and prognostic factor in metastatic rectal cancer: a multicenter retrospective cohort study

    Frontiers in Oncology, 2024

    DOI 10.3389/fonc.2024.1363305 PMID 38947890 5 citations (Europe PMC) Open-access full textSource: ORCID

  15. Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma

    Cureus, 2023

    DOI 10.7759/cureus.39726 PMID 37398833 3 citations (Europe PMC) Open-access full textSource: ORCID

  16. Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis

    Hepatology forum, 2023

    DOI 10.14744/hf.2022.2022.0010 PMID 36843898 3 citations (Europe PMC) Open-access full textSource: ORCID

  17. Use of Psycometric tests, Critical flicker frequency test and comparative evaluation of inflammation indicators in the diagnosis of covert hepatic encephalopathy

    The Turkish Journal of Gastroenterology, 2019

    DOI 10.5152/tjg.2019.01 Open-access full textSource: OpenAlex

  18. Can we predict hepatic encephalopathy? What do the hemogram parameters tell us?

    The Turkish Journal of Gastroenterology, 2019

    DOI 10.5152/tjg.2019.66 Open-access full textSource: OpenAlex